Canada markets closed

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1300-0.0200 (-13.33%)
At close: 03:44PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 17.23M
Enterprise Value 25.73M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)110.92
Price/Book (mrq)107.98
Enterprise Value/Revenue 172.70
Enterprise Value/EBITDA -6.17

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 330.00%
S&P500 52-Week Change 326.14%
52 Week High 30.1700
52 Week Low 30.0500
50-Day Moving Average 30.1286
200-Day Moving Average 30.0921

Share Statistics

Avg Vol (3 month) 3170.85k
Avg Vol (10 day) 3119.32k
Shares Outstanding 5132.51M
Implied Shares Outstanding 6152.13M
Float 896.08M
% Held by Insiders 134.93%
% Held by Institutions 10.00%
Shares Short (May 15, 2024) 4969
Short Ratio (May 15, 2024) 40
Short % of Float (May 15, 2024) 4N/A
Short % of Shares Outstanding (May 15, 2024) 40.00%
Shares Short (prior month Apr 15, 2024) 417.63k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 13, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar 13, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,289.83%

Management Effectiveness

Return on Assets (ttm)-40.64%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)165.59k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-92.30%
Gross Profit (ttm)N/A
EBITDA -3.55M
Net Income Avi to Common (ttm)-4.94M
Diluted EPS (ttm)-0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)826.7k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)9.2M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.31
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-3.25M
Levered Free Cash Flow (ttm)-551.78k